Stock N1BI34 NEUROCRINE BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Neurocrine Biosciences, Inc. Sao Paulo

Equities

N1BI34

BRN1BIBDR009

Delayed Sao Paulo
Other stock markets
 10:13:19 2024-07-12 am EDT 		5-day change 1st Jan Change
40.68 BRL +18.74% Intraday chart for Neurocrine Biosciences, Inc. +6.91% +25.94%
Jul. 09 RBC Cuts Price Target on Neurocrine Biosciences to $136 From $141, Keeps Sector Perform Rating MT
Jul. 03 ANALYST RECOMMENDATIONS : Alphabet, Nike, Nvidia, Tesla, Starbucks... Our Logo
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 127B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 117B
ARGENX SE Stock argenx SE
 27.77B -
BIONTECH SE Stock BioNTech SE
 20.44B -
GENMAB A/S Stock Genmab A/S
 16.62B
  1. Stock Market
  2. Equities
  3. NBIX Stock
  4. N1BI34 Stock
  5. Charts Neurocrine Biosciences, Inc.
  6. Sector Chart